insights_auto
Why is ORX down 3,00%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,84 SEK
arrow_downward
-3,00%(-0,026) 1D
13 қар., 13:32:06 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
295,07 млн
Avg. vol.
739,90 м.
Volume
604,38 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
295,07 млн
Avg. vol.
739,90 м.
Volume
604,38 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
FOREX.com
·
30 минут бұрын
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Yahoo Finance
·
1 сағат бұрын
What Invesco S&P 500 Equal Weight ETF (RSP) Sold: Moderna Leads on Nov. 11
Yahoo Finance
·
1 сағат бұрын
State Street SPDR Portfolio S&P 500 (SPYM) Adds Apple and Nvidia on Wednesday
Traders Union
·
1 сағат бұрын
S&P 500 drops 3% from all-time high while top stocks reach lowest valuations in years, Mike Bird notes
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com